Overview

8-Week Atopic Dermatitis (AD) Treatment Study

Status:
Completed

Trial end date:
2018-08-18

Target enrollment:

Participant gender:

Summary

This is a study to investigate the clinical effectiveness of the Sponsor's experimental cream treatment on eczema as measured by visual grading of SCORAD (scoring of atopic dermatitis).

Phase:

Phase 3

Details

Lead Sponsor:

Procter and Gamble

Treatments:

Desonide